Facebook
X
LinkedIn
ForwardLinda Ernst; Jeff Terry; Chandra Krishnan; Jennifer Black; Lauren Parsons; Consolato Sergi; Shipra Garg; Larry Wang; Nick Shillingford; Kristen Thomas; Katte Carreon; Mana Parast; Sanjita Ravishankar; Jie Zhang; Francois Cady; Stefan Kostadinov; Alysa Poulin; Charlotte Kim; Diana Corao-Uribe; Dehua Wang; Lea Surrey; Melissa Gener; Shahrazad Saab; Oscar Lopez-Nunez; Sandy Cope-Yokoyama; Kathryn McFadden; Naseem Uddin; Dina El Demellawy; Sean Ricciardo; Camilla Stefanovici; Selene Koo; Mike Covinsky; Rachel Mariani; Serena Tan; Jennifer Pogoriler; Claudia Salgado; Dina El Demellawy; Hao Wu; John Hicks; Archana Shenoy; Rachael Lowery; Kayla Marshall
2025 Fall Annual Meeting
The Fall 2025 Meeting will be held at the Downtown Marriott Hotel in Philadelphia, PA, from October 22-26. We look forward to seeing you there! Please visit the SPP website for further details. Please note, the course will not open until the CME portion of the meeting begins on October 23rd.
Registration Fees:
- SPP Member - $895.00
- Non-Member - $995.00
- Trainee/Emeritus Member- $445.00
- Non-Member Trainee - $545.00
If you prefer to pay by check, please fill out this form. An invoice will be emailed to you after receipt of the form. Once payment is received, instructions will be provided to complete registration.
Full refunds, less a $25.00 US process fee per registrant, will only be issued if you submit a request for cancellation in writing to [email protected] prior to September 25, 2025. No refunds will be granted after this date. Allow 6 weeks following the close of the meeting for refund processing. Refunds will not be given to registrants who do not attend without prior cancellation notice.
____
Social Outing - Separate Registration Required!
Our social outing will be to the Philadelphia Museum of Art on Saturday, October 25th. Meeting proceedings will end at 1PM; the first shuttle will depart from the Philadelphia Marriott to the museum at 1:30PM. Tickets include transportation to/from the museum, as well as admission to the museum. Space is limited! Signs ups close when availability runs out, or October 3rd, whichever comes first.
To register for the social outing, please click this link to register & pay ($45): https://ami.jotform.com/252454757700964
All who want to attend must register separately to attend.
_____
The SPP offers pathologists located outside of 'high income' nations, as deemed by the World Health Organization, access to educational programs at 30% of full cost. To learn more and apply for a discount, click HERE.
Target Audience
The education design of this activity addresses the needs of physicians and scientists in the field of pediatric, perinatal and general pathology who are involved in the diagnosis and/or treatment of pediatric patients with pathologic disorders.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss recent advances in the field of pediatric pathology that impact research and practice.
- Cite 2-3 examples of new information on the underlying etiologies and mechanisms of pediatric and perinatal diseases.
- Explain how to translate the latest developments in pediatric and perinatal pathology into clinical practice.
Physician Accreditation Statement
The Society for Pediatric Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
The Society for Pediatric Pathology designates this Other activity (blended live activity and enduring material) for a maximum of 18.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Pathology (ABPath) Continuous Certification
This activity is registered for American Board of Pathology Lifelong Learning (CME) credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to satisfy the Lifelong Learning (CME) requirements in the American Board of Pathology’s (ABPath) Continuous Certification (CC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for purpose of granting credit.
Successful completion of the CME activity allows the participant to earn up to 18.75 Lifelong Learning (CME) credits.
To receive credit, you must complete the evaluation and provide your ABPath Diplomate ID and Date of Birth (MM/DD). Your information will be shared with the ABPath through the ACCME Program and Activity Reporting System (PARS).
Instructions to Receive CME Credit
All attendees should complete the session specific evaluations as related to those portions of the 2025 Fall Annual Meeting that were attended, as well as the overall conference evaluation. You must be logged into EthosCE in order to access the evaluations and claim credit. You must claim credit by December 31, 2025.
The chart below outlines which portions of the 2025 Fall Annual Meeting are offered for CME credit and the maximum number of credit hours a physician can earn for each portion accredited for AMA PRA Category 1 Credit™. As this is an “Other activity” format you may claim credit based on your attendance at either the live session or for watching the recorded session up through December 31, 2025 when recorded content will expire. However, you may not claim credit more than once for a given session. Those sessions that will be recorded are marked with an asterisk (*).
Activity | CME Credit Hours |
| *Lotte Strauss Lecture: Reappraisal of Soft Tissue Myoepithelial Tumors... | 1.0 |
*Farber-Landing Lecture: Learning To Surf... | 1.0 |
*Platform I | 1.5 |
*Platform II | 1.5 |
*Platform III | 1.5 |
Poster Blitz | 1.25 |
| *Dr. Kevin E Bove Memorial Slide Session | 1.25 |
*Symposium: Immune Dysregulation Syndromes and Organ-Specific Pathologies | 4.0 |
| *Perinatal Slide Session | 1.0 |
| *COG Update: Ewing and Ewing Family Sarcomas | 1.25 |
| *Symposium: In Utero Diagnosis, Interventions, Pathologic Consequences and Genetics | 3.5 |
Total | 18.75 |
Contact Information
For questions regarding the accreditation of this meeting and the process for completing the evaluations and claiming credit, please contact the SPP at [email protected].
Available Credit
- 18.75 AMA PRA Category 1 Credit™
- 18.75 Participation Credit(s)
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Society for Pediatric Pathology does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Disclosure Information
The Society for Pediatric Pathology (SPP) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by SPP are required to disclose all financial relationships with any ineligible company within the past 24 months to the SPP. All financial relationships reported are identified as relevant and mitigated by the SPP in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by the SPP Education Committee to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by the SPP.
Planners and Managers
The following planners and managers have no relevant financial relationships with ineligible companies:
The following planners and managers have the following relevant financial relationships with ineligible companies:
M. Cristina Pacheco: Takeda Pharma, Contracted Research; Benjamin Wilkins: Sarepta Therapeutics, Consulting Fee
Faculty, Authors, Content Developers
The following faculty, authors, and content developers have no relevant financial relationships with ineligible companies:
Lectures/Symposia: Faizan Malik; Gino Somers; Anas Bernieh; Archana Shenoy; Sarangarajan Ranganathan; Pierre Russo; Maria Queenan; Rebecca Linn; Angela Viaene; Michele Paessler; Judith Kelsen; Jennifer Pogoriler; Nahla Khalek; William Peranteau; Gregory Heuer; Haley Crane; Desiree Fiorentino; Kelly Bailey
Perinatal Slide Session: Mohamed Youssef; Anh Huynh; Philip Katzman; Virginia Duncan; Jennifer Bloomer; Amelia Sybenga; Sanjita Ravishankar; Erin Alston
Platform/Poster Presenters: Selene Koo; Daniel Schlam; Faizan Malik; Shengmei Zhou; Caroline Stuhlfaut; Tammi Holle; Linda Ernst; Archana Sallagonda; Katelyn Moss; Sophia Bellegarde; Jason Jarzembowski; Terry Morgan; Lydia Du; Stephanie Torres; Shannon Kelley; Mohamad Alutaibi; Ayaka Silverman; Mande Beers; Brett Kurpiel; Shahrazad Saab; Zachary Kadow; Shahzaib Saleem; Lisa Andersen; Ginna Hernandez Velasquez; Francesca Vacca; Morvarid Elahi; Rebecca Collins; Omar Aljuboori; Muhammad Shaheen; Lydia Du; Ourania Parra; Ivan De La Riva; Shahrazad Saab; Meghan Driscoll; David Carpentieri; Kathryn Rice; Francesca Vacca; Ian Taylor-Cho; Mokhtar Abdelhammed; Madison Esposito; Rachel Mariani; Samantha Yasueda; Shannon Kelley; Mio Tanaka; Michael Koziela; Lydia Du; Shahzaib Saleem; Iqbal Ahmed; Mahreen Gilani; Laura Duzett; Ari Pape; Charles Blue; Rebecca Linn; Tiffany Sanchez; Stephanie Torres; Rebecca Linn; Bindu Challa; Ian Gelarden; Luis Mosquera Gomez; Bindu Challa; Bindu Challa; Maria Paola Bonasoni; Alexa Powers; Lin Chung; Philip Katzman; Mohamed Youssef; Aviv Oren; Harini Venkatraman Ravisankar
The following faculty, authors and content developers have the following relevant financial relationships with ineligible companies:
M. Cristina Pacheco: Takeda Pharm (Contracted Research); Benjamin Wilkins: Sarepta Therapeutics (Consulting Fee;) Tamir Diamond: Mirum Pharmaceuticals, Sarepta Theraputic (Consulting Fee); Lisa Young: Boehringer Ingelheim (Consulting Fee), Wolters Kluwer (Royalty), UpToDate (Royalty); Jim Treat: UpToDate (Royalty), Andrews Diseases of the Skin (Royalty); Palvella Inc (Consulting Fee), Arcutis (Consulting Fee), Nektar (Consulting Fee), Incyte (Consulting Fee), Palvella (Contracted Research); Jessica Davis: Bayer Pharmaceutics (Consulting Fee), Presage Biosciences (Consulting Fee)
Moderators
The following moderators have no relevant financial relationships with ineligible companies:
Katte Carreon; Jonathan Slack; Shahrazad Saab; Diana Corao-Uribe; Katte Carreon; Erin Alston; Angela Viaene; Archana Shenoy; Jonathan Slack; Pierre Russo
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Available Credit
- 18.75 ABPATH Lifelong Learning
- 18.75 AMA PRA Category 1 Credit™
- 18.75 Participation Credit(s)